Financial News · Live Terminal

Page 1165 of 3026

Update: Oppenheimer Raises Oracle Price Target to $275 From $235 Due to 'Strengthening Business Momentum', Maintains Outperform Rating

(Updates with the analyst's commentary.)Oppenheimer raised its price target on Oracle (ORCL) to $275 from $235, highlighting the company's fiscal Q4 resuklts, especially stronger expected (Oracle Cloud Infrastructure) growth."We believe our research mosaic (large partners and competitor checks, regression analysis and company-specific data) around enterprise IT demand, business activity, top of the funnel momentum, potential upside to estimates, and the earnings setup are positive for Oracle in F4Q," analysts Brian Schwartz and Idan Gutkind wrote in a Monday note.Oracle's partners also posted huge capital expenditures, which reflects "greater than expected IT demand," the analysts mentioned.Oracle has an average rating of overweight and mean price target of $254.38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $214.15, Change: $+0.47, Percent Change: +0.22%

$ORCL

Wire45d ago

First Atlas Resources Raises $2.1 Million in a Private Placement of Share Units

First Atlas Resources (HHE.CN) on Monday said it closed a bought-deal private placement of share units that raised $2.1 million.The company placed 30.3-million units, including the partial exercise of the over-allotment option, priced at $0.07 and of a share and a three-year warrant to buy a share for $0.09.common share purchase warrant. Each warrant shall entitle the holder to buy a share for $0.09 until June 8, 2029.Proceeds will be used for general working capital needs.Shares of the company were last seen down $0.0025 to $0.0475 on the Canadian Securities Exchange.

$HHE.CN

Wire45d ago

Jefferies Adjusts Price Target on American Water Works to $127 From $128, Maintains Hold Rating

American Water Works (AWK) has an average rating of hold and mean price target of $136.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $123.88, Change: $-0.59, Percent Change: -0.47%

$AWK

Insider Trading45d ago

Ezcorp Insider Sold Shares Worth $320,043, According to a Recent SEC Filing

Pablo Lagos Espinosa, Director, on June 05, 2026, sold 10,000 shares in Ezcorp (EZPW) for $320,043. Following the Form 4 filing with the SEC, Espinosa has control over a total of 217,543 Class A non-voting common shares of the company, with 217,543 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/876523/000087652326000055/xslF345X05/wk-form4_1780932381.xmlPrice: $32.21, Change: $+0.25, Percent Change: +0.80%

$EZPW

Wire45d ago

Apogee Shares Close to Reflect Atopic Dermatitis Prospects, RBC Says

Apogee Therapeutics (APGE) shares are close to "appropriately" reflecting their prospects in atopic dermatitis following its recent Part B results of zumilokibart, RBC said in a note Monday.RBC conducted a survey to gauge dermatologists' reactions to the data and how they might incorporate zumilokibart into their future clinical practice, the report said.The survey revealed slightly higher-than-expected potential switch expectations but lower-than-expected use in biologics-naives, the note said.The results improve confidence in RBC's $2.5 billion out-year US atopic dermatitis estimates, but not quite enough to warrant increasing its sales estimates, the report said."We are increasing our PoS to better reflect further de-risking both on the clinical and the market side, but we still believe shares are close to appropriately reflecting these prospects," the note said.RBC raised its price target to $97 from $82 while keeping its sector perform rating.Price: $84.66, Change: $-2.27, Percent Change: -2.61%

$APGE

Commodities45d ago

Renewable Fuel Stocks Fall as RNG Weakness Persists, TPH Says

Renewable fuel stocks fell last week as weakness in renewable natural gas firms overshadowed improving profit margins across several low-carbon fuel markets, TPH Energy Research said in a Monday note.Matthew Blair, analyst at TPH Energy, said that the renewable fuels sector declined 3% during the week, slightly worse than the S&P 500's 2.6% drop, with RNG-focused companies accounting for the four worst-performing stocks in the group.Agribusiness companies with exposure to biofuel feedstocks fared better. TPH said that Soybean crushers Bunge and Archer-Daniels-Midland were among the top performers, gaining 2.6% and 1.4%, respectively, as processing margins continued to improve.Margins for renewable diesel strengthened significantly, with low-carbon intensity renewable diesel indicators rising by $0.27 to $0.29 per gallon.The gains were driven by higher ultra-low sulfur diesel prices and stronger D4 Renewable Identification Number credits, while feedstock costs remained largely unchanged.RNG economics also improved despite the weakness in sector equities. Indicators for both landfill gas and dairy-based RNG increased by about $1 per million British thermal units, supported by stronger D3 RIN values.Elsewhere, Midwest ethanol margins rose $0.3 per gallon as corn prices eased, while soybean crushing margins increased by about $10 per metric ton on lower soybean costs.TPH said the renewable fuels sector is currently trading at a forward enterprise value-to-EBITDA multiple of 8.9 times, broadly in line with its three-year average valuation. Meanwhile, policy and regulatory developments continued to dominate investor attention.Renewable natural gas industry groups launched legal challenges against the US Environmental Protection Agency's decision to reduce the 2025 cellulosic biofuel Renewable Volume Obligation and exclude electric vehicle charging credits from the Renewable Fuel Standard program.Simultaneously, the American Fuel & Petrochemical Manufacturers filed its own lawsuit challenging the EPA's biofuel blending mandates for 2026/27.Germany's revised renewable fuel legislation came into effect, introducing new compliance requirements for fuel suppliers and renewable energy producers.On the corporate front, renewable fuels producer Clean Energy Fuels began commercial production of RNG at its Millenkamp dairy project in Idaho, adding to the company's portfolio of renewable gas assets that supply the transportation sector.Though improving margins supported fundamentals, TPH analysts said investors remained cautious amid ongoing policy uncertainty and legal disputes surrounding US renewable fuel mandates.Price: $126.44, Change: $-0.02, Percent Change: -0.02%

$ADM$BG

Equities45d ago

Netanyahu Says Israel to Hold Fire in Iran for Now, Bloomberg Reports

Commodities45d ago

US Land Rig Data Diverges as Enverus Reports Decline, Baker Hughes Posts Gain, TPH Says

US land drilling activity delivered mixed signals last week, with data from two major industry trackers diverging on the direction of rig counts, TPH Energy Research analyst Jeff LeBlanc said in a note on Monday.According to Enverus, the US land rig count fell by nine rigs week-over-week to 583, leaving the trailing four-week change at a modest gain of one rig.In contrast, Baker Hughes (BKR) reported an increase of eight rigs during the week, bringing its US rig count to 549 and extending the trailing four-week gain to six rigs.Enverus data showed horizontal drilling activity declining by nine rigs from the previous week, with privately held operators accounting for the majority of the reduction, down eight rigs.Regionally, the steepest declines were recorded in the Haynesville and Permian basins, which lost five and four rigs, respectively.Despite the reported decreases, the weakness is more likely attributable to data volatility than to meaningful operational changes.Activity reductions among larger Permian operators appear unlikely under current market conditions, although some rig transfers among private operators may have contributed to the reported shifts.Similarly, Haynesville rig trends do not appear consistent with underlying operational activity, as affected drillers continue to indicate broadly flat rig counts in publicly reported fleet data.Offshore, US Gulf of America drilling activity declined by one floating rig over the week, leaving 16 floaters and three jackups actively working, LeBlanc said.Meanwhile, Canadian drilling activity strengthened, rising by seven rigs during the week to 167 active rigs, compared with 112 rigs operating during the same period a year earlier.Price: $65.01, Change: $+2.42, Percent Change: +3.87%

$BKR

US Markets45d ago

Amazon, Corning Agree to Multibillion-Dollar Fiber Supply Pact for US Data Centers

Amazon.com (AMZN) agreed to a multibillion-dollar deal with specialty glass maker Corning (GLW) to secure optical fiber, cable, and connectivity components for its US data center infrastructure.The deal includes expansion of Corning's facilities in North Carolina and creation of 1,000 new jobs at the site, Amazon said Monday."This agreement with Amazon represents a significant milestone for Corning and for American manufacturing," Corning CEO Wendell Weeks said in a statement. "Amazon's investment will help us expand production, create 1,000 new advanced manufacturing jobs at our facilities, and lead the way toward building a resilient US manufacturing base.""Amazon's data centers power the services millions of people and businesses rely on," the e-commerce company said. "Corning's fiber optics are a critical part of that infrastructure, and together, these investments help fuel the US economic engine."Corning shares rose 6.8% in Monday trading and have more than doubled this year. Amazon gained 0.5%, and the stock has climbed 7.1% this year.Amazon will also work with Corning to expand its fiber optic technician training program with Catawba Valley Community College, covering fiber manufacturing and technical roles.In May, Corning partnered with Nvidia (NVDA) to boost its optical connectivity manufacturing capacity and support AI factory buildouts. The deal included construction of three new facilities in North Carolina and Texas.In June 2025, Amazon announced a $10 billion investment in North Carolina for cloud infrastructure development. Since 2010, the company has poured $20 billion into the state, creating 26,000 jobs.Price: $247.28, Change: $+1.25, Percent Change: +0.51%

$AMZN$GLW$NVDA

Mining & Metals45d ago

Altius Minerals to Join the S&P/TSX Composite Index; Shares up 3%

Altius Minerals' (ALS.TO) common shares will be added to the S&P/TSX Composite Index, effective prior to the open of trading on June 22, 2026, as disclosed by S&P Dow Jones Indices on June 5, 2026, the company said on Monday."Inclusion in Canada's premier market index, amongst a humbling list of Canada's strongest public companies, represents an honour for the entire team at Altius," said Brian Dalton, Chief Executive Officer. "It is certainly fair to say that this achievement was not on our list of goals when we established Altius 29 years ago as a junior capital pool company. We would like to offer a sincere thank you to our shareholders for their long-term support and encouragement while also pledging to continue to work hard to find ways to grow enduring value on your behalf."The company's shares were last seen up $1.70 at $57.08 on the Toronto Stock Exchange.Price: $57.15, Change: $+1.77, Percent Change: +3.20%

$ALS.TO

International45d ago

May US Median Inflation Expectations Slow for Short Term, According to NY Fed Survey

Consumer expectations for one-year US inflation growth decreased to a 3.5% gain in May from a 3.6% gain in the previous month, according to a survey released by the New York Federal Reserve Bank on Monday.The median inflation expectations remained unchanged at 3.1% gain for the three-year period and at a 3.0% gain for five years ahead.The median inflation uncertainty increased to 3.6% from 3.5% in the one-year horizon and increased to 3.5% from 3.2% for the three-year outlook.Median home price change expectations rose to 3.5% from 3.0% while home price uncertainty declined to a 3.7% increase from a 4.0% increase in the previous month.The median one-year expectations commodity prices growth rose for food and rent and declined for gas, medical care, college education and gold.Earnings growth expectations remained unchanged in May at 2.7%. Expectation for losing a job increased while those for finding a job decreased. Expectations for higher unemployment one year from now decreased.

Equities45d ago

Shell Launches Exchange Offers for Outstanding Unregistered Notes

Shell (SHEL.L, SHELL.AS) initiated exchange offers for six series of outstanding notes issued by Shell Finance US that are not registered under the US Securities Act of 1933.The tendered securities, which are fully guaranteed by the British energy giant, will be exchanged for new registered notes with "substantially identical" terms, according to a Monday filing. The offer will expire on July 8.The transaction covers the outstanding $920.7 million of 3.875% notes due 2028, $2.06 billion of 6.375% notes due 2038, $802.1 million of 5.500% notes due 2040, $691.2 million of 5.125% notes due 2041, $993.7 million of 3.125% notes due 2049, and $876.8 million of 3% notes due 2051.

$SHEL.L$SHELL.AS

Wire45d ago

HCW Biologics Registers Resale of Up to 5.7 Million Shares

HCW Biologics (HCWB) said Monday it is registering for the resale of up to 5.7 million common shares by selling stockholders connected to a May private placement.The shares include 427,046 already issued shares, 2.4 million shares tied to pre-funded warrants and 2.8 million shares tied to common stock purchase warrants, the company said.The May private placement sold 2.8 million units at $1.405 each and raised about $4 million in gross proceeds, the company added.HCW Biologics said it will not receive proceeds from the resale, though it may receive up to about $3.6 million if the common warrants are exercised for cash.The company added any warrant exercise proceeds would be used for general corporate purposes, including clinical and preclinical programs, research and development, working capital and other needs.Shares of the company were down more than 7% in Monday trading.Price: $1.50, Change: $-0.13, Percent Change: -7.98%

$HCWB

Commodities45d ago

Europe's Diesel, Jet Fuel Imports Shrink Amid Iran Conflict, Bloomberg Analysis Says

European imports of diesel and jet fuel remained stagnant in May, tightening regional energy supplies as the Middle East conflict continues to disrupt global shipping routes, a Bloomberg analysis showed on Monday.Shipments into the European Union and the UK totaled 1.16 million barrels per day last month, a decline of over one-third compared to the same period a year ago.Though the figure represents a marginal increase from April's arrivals of 1.09 million b/d, the lowest level recorded since at least 2015, it underscores a persistent supply deficit.Europe relies heavily on imports to meet domestic demand for diesel and jet fuel, with a significant portion traditionally sourced from the Middle East.However, ongoing instability near the Strait of Hormuz, the critical chokepoint connecting Persian Gulf energy infrastructure to global markets, has stifled supply flows, contributing to upward pressure on prices.

Commodities45d ago

Stronger LNG Prices Lift Venture Global Valuation, 2026 Outlook, TPH Says

Driven by lower Henry Hub prices and stronger international LNG pricing, TPH Energy Research has raised Venture Global's (VG) Q2 2026 adjusted EBITDA forecast to $2.86 billion from $2.75 billion.This is above the Street estimate of $2.47 billion.For full-year 2026, the firm lifted its adjusted EBITDA estimate to $8.79 billion from $8.60 billion, compared with a Street forecast of $8.30 billion and a consensus range of $7.48 billion to $8.77 billion.TPH lowered its 2027 adjusted EBITDA forecast by about $200 million to $6.46 billion from its prior outlook, while the Street expects $6.60 billion.The revision reflects about 2.5 million metric tons per annum of new five-year contracts signed this year, which TPH modeled at a rate of $4.After assigning those contracts to Plaquemines Phase I, TPH increased its committed 2027 volumes to 89% from 75%, reducing open capacity and lowering its earnings outlook for the facility despite stronger pricing.TPH expects CP2 to begin operations in the third quarter of 2027 and said an earlier startup would improve its 2027 forecast.TPH expects global LNG markets to move into oversupply by mid-2028, with Venture Global projected to have significant uncontracted capacity, with its facilities expected to be 54% contracted in 2028 and 50% contracted in 2029.The firm noted that a $1 change in margin could affect 2029 EBITDA by $1.8 billion to $1.9 billion, while a decline in international LNG prices toward the $6 to $7 range would materially reduce its earnings outlook.TPH raised its price target on Venture Global from $8 to $17 after updating its model for current commodity prices and recent contracting activity, while maintaining a Hold rating on the stock.Price: $13.04, Change: $+0.23, Percent Change: +1.84%

$VG

Wire45d ago

Catheter Precision's Flyte Acquires 7.5% Stake in Volato

Catheter Precision (VTAK) said Monday its Flyte subsidiary has made an investment in Volato (SOAR), acquiring roughly 2.9 million shares, representing about 7.5% of the company's outstanding stock.The investment is part of a broader financing led by Catheter and other institutional investors, with Volato raising $2.2 million through a strategic investment aimed at strengthening its balance sheet and supporting its shift toward AI and infrastructure-related opportunities.The company added that the investment is intended to support potential collaboration across the private aviation ecosystem, focusing on improving access, efficiency and innovation across both companies' platforms.Catheter Precision shares rose nearly 3%, while Volato fell 31% in Monday trading.Price: $1.06, Change: $+0.03, Percent Change: +2.91%

$SOAR$VTAK

US Markets45d ago

Cerebras To Benefit From Growing Demand For Fast AI Inference, Morgan Stanley Says

Cerebras Systems (CBRS) is expected to benefit from rising demand for low-latency artificial intelligence inference, Morgan Stanley said in a client note emailed Monday.Latency is the time it takes to generate AI tokens, or tiny units of data, according to information posted on Nvidia's (NVDA) website. Low latency is crucial for real-time AI applications as it enhances user experience.However, low latency often increases costs due to the need for more powerful hardware and real-time processing capabilities."As AI workloads become increasingly reasoning-intensive, demand for fast, low-latency inference is growing rapidly," Morgan Stanley said. "Supported by a large contracted backlog and a 750 (megawatt) committed capacity agreement, we believe Cerebras is well positioned to capture this opportunity."Shares of the chip designer, which went public last month, soared 18% intraday Monday.The brokerage initiated Cerebras' coverage with an overweight rating and a $250 price target."This is a unique chance to invest in an AI processor company with a first-mover advantage against (Nvidia), and offers substantial upside as the category evolves," according to the report.The low-latency segment could account for 10% or more of inference hardware sales over the next few years, the brokerage said.Contracted revenue will bring in $6 billion in revenue, or 1% market share of overall processors, by calendar year 2028, Morgan Stanley said, pointing to upside potential.However, competition in the category is expected to intensify over time."Nvidia's acquisition of the assets of Groq -- an AI processing company specializing in a low latency approach -- is worth watching," Morgan Stanley said.Price: $235.30, Change: $+34.29, Percent Change: +17.06%

$CBRS$NVDA

Wire45d ago

Griffon Enters Joint Venture Deal for AMES Australasia Sale

Griffon (GFF) said Monday it has agreed to sell its AMES Australasia business to a joint venture it is forming with an investment group led by AMES management, backed by Australian financial investors.Under the deal, Griffon will receive $185 million at closing and a $50 million subordinated note in the joint venture, the company said. It will have a 49% equity stake, while the remaining 51% will be owned and controlled by the investor group led by Simon Hupfeld, who will become executive chairman after closing, the company said.The joint venture will be funded through a mix of committed debt financing, partner equity, and Griffon's subordinated note, the company said, adding that the transaction is set to close by its fiscal year ending September.Shares of Griffon were up 1.6% in Monday trading.Price: $86.87, Change: $+1.37, Percent Change: +1.60%

$GFF

Asia Markets45d ago

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, lifting 0.82% to 1,874.41 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion (EVAX), which rose 7% and 4.5% respectively. They were followed by accommodations booking company trivago (TRVG) and telecommunications company Nokia (NOK), which increased 4.4% and 1.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Cellectis (CLLS), which fell 2.9% and 2.3% respectively. They were followed by pharmaceutical company Sanofi (SNY) and biopharmaceutical company Grifols (GRFS), which were down 2% each.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which advanced 4.5% and 3.3% respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Amarin (AMRN), which were up 1.7% and 1.6% respectively.The decliners from the UK and Ireland were led by biotech company Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 4.2% and 2.4% respectively. They were followed by utilities company National Grid (NGG) and pharmaceutical company GSK (GSK), which lost 2% and 1.2% respectively.

$AMRN$AUTL$BDRX$BP$CLLS$EVAX$GRFS$GSK$MREO$NCNA$NGG$NOK$NVO$SNY$SQNS$TRVG

Showing 23281-23300 of 60514

Wire45d ago

Financial News · Live Terminal

Update: Oppenheimer Raises Oracle Price Target to $275 From $235 Due to 'Strengthening Business Momentum', Maintains Outperform Rating

Top Midday Stories: US Weighs Financial Stakes in AI Firms; Google, Nvidia Turn to Intel as TSMC Struggles With Demand

First Atlas Resources Raises $2.1 Million in a Private Placement of Share Units

Jefferies Adjusts Price Target on American Water Works to $127 From $128, Maintains Hold Rating

Ezcorp Insider Sold Shares Worth $320,043, According to a Recent SEC Filing

Apogee Shares Close to Reflect Atopic Dermatitis Prospects, RBC Says

Renewable Fuel Stocks Fall as RNG Weakness Persists, TPH Says

Netanyahu Says Israel to Hold Fire in Iran for Now, Bloomberg Reports

US Land Rig Data Diverges as Enverus Reports Decline, Baker Hughes Posts Gain, TPH Says

Amazon, Corning Agree to Multibillion-Dollar Fiber Supply Pact for US Data Centers

Altius Minerals to Join the S&P/TSX Composite Index; Shares up 3%

May US Median Inflation Expectations Slow for Short Term, According to NY Fed Survey

Shell Launches Exchange Offers for Outstanding Unregistered Notes

HCW Biologics Registers Resale of Up to 5.7 Million Shares

Europe's Diesel, Jet Fuel Imports Shrink Amid Iran Conflict, Bloomberg Analysis Says

Stronger LNG Prices Lift Venture Global Valuation, 2026 Outlook, TPH Says

Catheter Precision's Flyte Acquires 7.5% Stake in Volato

Cerebras To Benefit From Growing Demand For Fast AI Inference, Morgan Stanley Says

Griffon Enters Joint Venture Deal for AMES Australasia Sale

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

Update: Oppenheimer Raises Oracle Price Target to $275 From $235 Due to 'Strengthening Business Momentum', Maintains Outperform Rating

Top Midday Stories: US Weighs Financial Stakes in AI Firms; Google, Nvidia Turn to Intel as TSMC Struggles With Demand

First Atlas Resources Raises $2.1 Million in a Private Placement of Share Units

Jefferies Adjusts Price Target on American Water Works to $127 From $128, Maintains Hold Rating

Ezcorp Insider Sold Shares Worth $320,043, According to a Recent SEC Filing

Apogee Shares Close to Reflect Atopic Dermatitis Prospects, RBC Says

Renewable Fuel Stocks Fall as RNG Weakness Persists, TPH Says

Netanyahu Says Israel to Hold Fire in Iran for Now, Bloomberg Reports

US Land Rig Data Diverges as Enverus Reports Decline, Baker Hughes Posts Gain, TPH Says

Amazon, Corning Agree to Multibillion-Dollar Fiber Supply Pact for US Data Centers

Altius Minerals to Join the S&P/TSX Composite Index; Shares up 3%

May US Median Inflation Expectations Slow for Short Term, According to NY Fed Survey

Shell Launches Exchange Offers for Outstanding Unregistered Notes

HCW Biologics Registers Resale of Up to 5.7 Million Shares

Europe's Diesel, Jet Fuel Imports Shrink Amid Iran Conflict, Bloomberg Analysis Says

Stronger LNG Prices Lift Venture Global Valuation, 2026 Outlook, TPH Says

Catheter Precision's Flyte Acquires 7.5% Stake in Volato

Cerebras To Benefit From Growing Demand For Fast AI Inference, Morgan Stanley Says

Griffon Enters Joint Venture Deal for AMES Australasia Sale

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading